* Panel votes 7-5 to recommend approval with conditions
* FDA will consider panel’s advice
GAITHERSBURG, Md., March 12 (Reuters) - An implanted Medtronic Inc (MDT.N) brain device should be approved for treating epilepsy, U.S. government advisers said on Friday.
A Food and Drug Administration advisory panel voted 7-5 to recommend approval of the Deep Brain Stimulation (DBS) therapy for epilepsy, a brain disorder that causes seizures. The device already is sold for treating Parkinson’s disease and other disorders.
The panel said the FDA should require warnings about suicidal behavior and depression and follow-up studies of up to five years after approval.
The FDA will consider the panel recommendation. The agency usually approves products that win support from advisory committees. (Reporting by Lisa Richwine; editing by Andre Grenon)